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Abstract
Cerebral blood flow is an important process for brain functioning and its dysregulation is implicated in multiple neuro-
logical disorders. While environmental risk factors have been identified, it remains unclear to what extent the flow is
regulated by genetics. Here we performed heritability and genome-wide association analyses of cerebral blood flow in a
population-based cohort study. We included 4472 persons free of cortical infarcts who underwent genotyping and phase-
contrast magnetic resonance flow imaging (mean age 64.8 10.8 years). The flow rate, cross-sectional area of the vessel,
and flow velocity through the vessel were measured in the basilar artery and bilateral carotids. We found that the flow
rate of the basilar artery is most heritable (h2 (SE)¼ 24.1 (9.8), p-value¼ 0.0056), and this increased over age. The
association studies revealed two significant loci for the right carotid artery area (rs12546630, p-value¼ 2.0 108) and
velocity (rs2971609, p-value¼ 1.4 108), with the latter showing a concordant effect in an independent sample
(N¼ 1350, p-value¼ 0.057, meta-analyzed p-value¼ 2.5 109). These loci were also associated with other cerebral
blood flow parameters below genome-wide significance, and rs2971609 lies in a known migraine locus. These findings
establish that cerebral blood flow is under genetic control with potential relevance for neurological diseases.
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Introduction
The cerebral circulation consists of an intricate system
of blood vessels that supply the brain with nutrients.
The ﬂow of blood to the brain parenchyma is tightly
regulated,1–3 with deviations from this resulting in func-
tional impairments. Both ischemia and hyperemia are
associated with neurological diseases, including
Alzheimer’s disease,4 other neurodegenerative dis-
orders,5 stroke,6 and small vessel disease.7 It is therefore
imperative to identify factors that inﬂuence cerebral
blood ﬂow.
Numerous environmental factors have been asso-
ciated with cerebral blood ﬂow, among which are phys-
ical activity,8 psychological stress,9 and high altitude.10
Some studies have also hinted at an inﬂuence of
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genetics, with reports of cerebral blood ﬂow dysregula-
tion in mutation carriers of diseases, such as the COMT
Val158Met mutation11 and HTT CAG repeats.12
However, the extent to which genetics contributes to
the variability in cerebral blood ﬂow is yet to be deter-
mined. Furthermore, only small candidate gene studies
have been published, while there have been no reports
of unbiased genome-wide studies. Identiﬁcation of gen-
etic variants associated with cerebral blood ﬂow could
provide insight into neurological disorders that are
related to ﬂow abnormalities.
Here we systematically map the heritability of cere-
bral blood ﬂow in a large, population-based cohort
study, followed by genome-wide association studies
and independent replication.
Material and methods
Study population
This study was embedded in the Rotterdam Study,13 a
Dutch population-based cohort study including a total
of 14,926 participants who were aged 45 years or over at
enrolment. The cohort was designed to investigate
causes and determinants of chronic diseases in the eld-
erly, although participants were not selected for the
presence of diseases or risk factors. The participants
were recruited in three batches: in 1990 (RS-I), in
2000 (RS-II), and in 2006 (RS-III). Genotyping was
successfully performed in 11,496 participants of
European descent. Since 2005, all participants under-
went brain magnetic resonance imaging (MRI) to exam-
ine the causes and consequences of age-related brain
changes.14 Until 2013, a total of 5806 unique individuals
were scanned, of which 4864 had genetic data available.
The Rotterdam Study has been approved by the insti-
tutional review board of Erasmus MC University
Medical Center (Medical Ethics Committee), in accord-
ance with the Helsinki Declaration of 1975 (and
revised in 1983), and in accordance with the
Population Study Act Rotterdam Study, executed by
the Ministry of Health, Welfare and Sports of the
Netherlands. All participants provided written
informed consent to participate in the study and to
obtain information from their treating physicians.
Genotyping
Genotyping was performed with the Illumina 550K,
550K duo, and 610 quad arrays.13 We then removed
samples with call rate below 97.5%, gender mismatch,
excess autosomal heterozygosity, duplicates or family
relations and ancestry outliers, and variants with call
rate below 95.0%, failing missingness test, Hardy–
Weinberg equilibrium p-value <106, and minor allele
frequency <1%. Genotypes were imputed to the 1000
Genomes phase I version 3 reference panel (all popula-
tion) by using the MACH/minimac software.15
Image acquisition and processing
MRI scanning was performed on a dedicated 1.5-T
MRI unit with an eight-channel head coil (Signa HD
platform, GE Healthcare, Milwaukee, USA). The MRI
protocol included high-resolution axial sequences (T1-
weighted, T2-weighted, and ﬂuid attenuated inversion
recovery (FLAIR)), as well as 2D phase-contrast ima-
ging. A detailed description of the MRI protocol was
presented elsewhere.14 All scans were visually inspected
by trained raters for cortical infarcts and, if present, the
scan was excluded since infarcts may have a large eﬀect
on the measurements of cerebral blood ﬂow (N¼ 196).
For cerebral blood ﬂow measurement, 2D phase-
contrast imaging was performed as described previ-
ously.16 In short, a sagittal 2D phase-contrast MRI
angiographic scout image was performed. On this
scout image, a transverse imaging plane perpendicular
to both the precavernous portion of the internal carotid
arteries and the middle part of the basilar artery was
chosen for a 2D gradient-echo phase-contrast sequence
(repetition time¼ 20ms, echo time¼ 4ms, ﬁeld of
view¼ 19 19 cm2, matrix¼ 256 160, ﬂip angle¼ 8,
NEX¼ 8, bandwidth¼ 22.73 kHz, velocity enco-
ding¼ 120 cm/s, slice thickness¼ 5mm). Acquisition
time was 51 s and no cardiac gating was performed.17
Measures of cerebral blood ﬂow were derived from the
phase-contrast images by using interactive data lan-
guage-based custom software (Cinetool version 4;
General Electric Healthcare). Two experienced MRI
technicians manually marked the basilar artery as well
as the left and right carotid arteries with excellent
agreement (inter- and intra-rater correlation both pre-
viously determined to be >0.94).16 The cross-sectional
area of these vessels (cm2) and ﬂow velocity (cm/sec)
through them were determined from these regions of
interest. The ﬂow rate (mL/s) for each vessel was cal-
culated from the area and velocity. Additionally, the
total cerebral blood ﬂow was calculated by summing
ﬂow rates for the basilar and carotid arteries and
expressed in mL/min. Details on the assessment of cere-
bral blood ﬂow can be found in a previous report.16
Outlying values of more than 3.5 standard deviation
from the mean were excluded from the analysis to pre-
vent eﬀects being driven by a few individuals. Finally,
we performed a rank normal transformation of the data
to ensure that the variables are in a normal distribution,
since the heritability estimation is sensitive to devi-
ations from this.
To determine brain volume, T1 images were seg-
mented into supratentorial gray matter, white matter
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and cerebrospinal ﬂuid by using a k-nearest neighbor
algorithm.18 White matter lesions were segmented by
using the T1 tissue maps and an automatically detected
threshold for the intensity of FLAIR scans.19 Visual
inspection of the segmentations led to the exclusion of
197 poor quality scans, leaving 4472 individuals for
analysis.
Heritability analysis
To estimate heritability in our sample of unrelated indi-
viduals, we implemented Genome-wide Complex Trait
Analysis (GCTA).20 Brieﬂy, this method compares gen-
etic similarity between individuals with phenotypic
similarity to estimate the amount of variance explained
by genetics. For this, a genetic relationship matrix was
calculated as previously described;21 1000 Genomes
imputed genotypes were ﬁltered on imputation quality
(R2< 0.5) and allele frequency (MAF< 0.01) and used
to calculate pairwise genetic relatedness between all
individuals. For pairs with more than 0.02 genotype
similarity, one individual was randomly removed.
We estimated the heritability of the area, velocity,
and ﬂow for each of the three vessels, as well as the
total cerebral blood ﬂow. All analyses were adjusted
for age, age2, sex, intracranial volume (model 1) and,
to take into account any atrophy, additionally for the
total supratentorial brain tissue volume (model 2). To
determine patterns of heritability across the age range
of our population, we performed a sliding window ana-
lysis. Individuals were ranked on the basis of their age
and the heritability analyses were performed in the
youngest 2000. Next, the study population shifted in
10 equal steps to the oldest 2000 individuals.
Genome-wide association analysis
Genome-wide association analyses were performed on
the cerebral blood ﬂow parameters for the ﬁrst model
by using the HASE software.22 Variants were removed
if they had an R2< 0.5 and an MAF< 0.05. Analyses
were performed in the three subcohorts of the
Rotterdam Study separately and meta-analyzed with
the METAL software.23 Variants with a p-value
<5 10-8 were considered genome-wide signiﬁcant.
Replication
Replication of genome-wide signiﬁcant variants was
performed in the Age, Gene/Environment
Susceptibility (AGES) study, a population-based study
in Reykjavik, Iceland, and which is described in detail
elsewhere.24 Brieﬂy, genotyping was performed with the
Illumina HumanCNV370 chip and data were imputed
to the same 1000 Genomes reference panel. Cerebral
blood ﬂow was measured in a similar way by using 2D
gradient-echo phase contrast sequence (FOV 220 mm,
matrix 25 256, TE 6.2ms, TR 20ms, ﬂip angle 9, vel-
ocity encoding 100 cm/s, slice thickness 5mm). The
images were analyzed using the software package
FLOW25 by a single investigator (S.S.), with excellent
agreement between repeated cerebral blood ﬂow meas-
urements in 20 scans (coeﬃcients of variation 1.7).
Results
Study population
The characteristics of the population included in this
study are shown in Table 1. The mean age was 64.8
(standard deviation 10.8) years, ranging from 45.7 to
97.9. The total brain volume was on average 82% of
intracranial volume. The majority of the cerebral blood
ﬂow was provided by the carotids (80%), which was
comparable between left and right.
Heritability analysis
Table 2 shows the heritability estimates of cerebral
blood ﬂow. The ﬂow through the vessel, rather than
the area or the velocity, was the most heritable param-
eter. The highest heritability was for the basilar artery
(h2¼ 21.8) followed by the total cerebral blood ﬂow
(h2¼ 16.1). Additional adjustment for brain volume
slightly increased the heritability estimates.
Table 1. Study population characteristics.
Characteristic
Rotterdam
Study
(N¼ 4472)
AGES-
Reykjavik
(N¼ 1350)
Age, in years 64.8 10.8 79.7 4.7
Men, N (%) 1981 (44.3%) 513 (38.0%)
Intracranial volume, in cm3 1141.4 114.9 1485.8 144.0
Brain volume, in cm3 937.5 100.9 1060.3 97.1
Flow rate, in cm3/s
Basilar artery 1.7 0.6 1.0 0.74
Left carotid 3.5 0.9 2.9 1.0
Right carotid 3.5 0.9 3.0 1.0
Vessel cross-sectional area, in cm2
Basilar artery 0.29 0.05 0.24 0.06
Left carotid 0.35 0.07 0.35 0.07
Right carotid 0.36 0.07 0.36 0.08
Flow velocity, in cm/s
Basilar artery 11.2 4.3 7.5 2.9
Left carotid 15.2 4.6 10.2 2.8
Right carotid 14.9 4.5 10.4 3.1
Note: Values represent mean standard deviation, unless otherwise
stated.
1600 Journal of Cerebral Blood Flow & Metabolism 38(9)
By using the sliding window approach, we found
that the heritability was higher in the older age
groups, most noticeable for the basilar artery param-
eters (Figure 1, Supplementary Table S1). The results
were similar after adjustment for total brain volume
(Supplementary Figure 1).
Genome-wide association analysis
Next, we performed genome-wide association studies of
cerebral blood ﬂow parameters and identiﬁed two sig-
niﬁcant loci (Figure 2, all variants with p-values <106
are provided in Supplementary Table S2). These were
6q16.1 for the ﬂow velocity through the right carotid
(rs2971609, p-value¼ 1.4 108) and 8q24.23 for the
cross-sectional area of the right carotid (rs12546630,
p-value¼ 2.0 108). Both top variants were intronic
(Figure 3), with 6q16.1 being a known locus for
migraine.26 When examining the two loci in relation to
all cerebral blood ﬂow parameters (Table 3), we found
that the 6q16.1 locus was associated with a larger area
and a lower velocity in both carotids, while 8q24.23 was
associated with larger area and ﬂow rate of both caro-
tids. The results did not diﬀer materially after further
adjustment for brain volume (Supplementary Table S3).
Replication
We attempted replication of the two signiﬁcant loci in
an independent cohort and found a borderline signiﬁ-
cant and concordant signal for 6q16.1 for the ﬂow
velocity through the right carotid (rs2971609,
p-value¼ 0.057), which is increasing in signiﬁcance
after meta-analysis (p-value¼ 2.5 109). There was
no apparent association for 8q24.23 in the replication
cohort (p-value¼ 0.83, beta in opposite direction).
Discussion
We ﬁnd that, in the general population, the total cere-
bral blood ﬂow is partly determined by genetic factors,
with the highest heritability for the ﬂow through the
basilar artery. The genetic contribution tends to be
more prominent at older age (>65 years). We also iden-
tify the ﬁrst genome-wide signiﬁcant loci for cerebral
blood ﬂow, one of which showing a similar eﬀect in an
independent cohort.
While we are not aware of other heritability studies
of cerebral blood ﬂow, the fact that it is heritable
should not be surprising given many reports on the
heritability of brain structure. Most such studies were
performed in twins, which produce systematically
higher estimates than the population-based approach
we used here.20 Indeed, most heritability estimates of
brain traits were considerably higher. In contrast, the
few studies in unrelated individuals that used common
genotyped variants reported substantially lower herit-
abilities than the twin-based approach.27–30
Nevertheless, the proportion of the phenotypic variance
explained by genetics is less than half that of height,
which is estimated at 60% following a similar approach
to our study.31 Cerebral blood ﬂow might therefore be
more susceptible to environmental factors such a per-
son’s lifestyle, which could in turn inﬂuence
Table 2. Heritability of cerebral blood flow parameters in the Rotterdam Study.
Model 1 Model 2
Parameter N h2 (SE) P h2 (SE) P
Total cerebral blood flow 3485 16.1 (9.8) 0.048 17.8 (9.8) 0.033
Flow rate
Basilar artery 3489 21.8 (9.8) 0.011 24.1 (9.8) 0.0056
Left carotid 3480 9.5 (9.8) 0.17 10.4 (9.8) 0.15
Right carotid 3481 13.8 (9.9) 0.081 9.9 (9.8) 0.16
Vessel area
Basilar artery 3475 9.0 (9.2) 0.14 9.7 (9.2) 0.13
Left carotid 3482 0.0 (9.4) 0.50 0.0 (9.4) 0.50
Right carotid 3482 0.0 (9.6) 0.50 0.0 (9.6) 0.50
Flow velocity
Basilar artery 3451 12.1 (9.8) 0.10 13.4 (9.8) 0.082
Left carotid 3445 7.5 (9.9) 0.23 8.5 (10.0) 0.20
Right carotid 3449 3.5 (9.6) 0.36 3.5 (9.6) 0.36
Note: Heritability estimates of cerebral blood flow parameters under two models: adjusting for age, age2, sex, intracranial volume (model 1) and
additional for brain volume (model 2).
h2¼ heritability; N¼ sample size; SE¼ standard error.
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cardiovascular health. If some of these consequences
are vessel-speciﬁc, this may help to explain the diﬀer-
ences between basilar artery and the carotids.
Besides the ﬂow rate, we also examined its two com-
ponents: the vessel’s cross-sectional area and the ﬂow
velocity. Interestingly, these were both less heritable
than the ﬂow rate. One explanation for this is that
ﬂow needs to be constant to provide the brain with
suﬃcient nutrients, while the area or velocity may
vary as each can compensate the other. Since ﬂow is
most crucial for the brain to function adequately, this
might explain why it is under tighter genetic control.
Alternatively, there could be more intra-individual vari-
ation in the area and velocity compared to ﬂow, also
resulting in heritability diﬀerences between the
parameters.
Another intriguing ﬁnding was that ﬂow parameters
were generally more heritable with increasing age. This
trend was most apparent for the basilar artery, reaching
heritability estimates over 60% around 70 years of
age. Environmental exposures accumulate over the life-
time while a person’s genetic make-up remains stable.
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Figure 1. Heritability of cerebral blood flow parameters across age. A sliding window approach showing the heritability of the flow
rate (top), vessel area (middle), and flow velocity (bottom) for three major cerebral arteries: the basilar artery in red, the left carotid
artery in green, and the right carotid artery in blue. The results are adjusted for age, age2, sex, and intracranial volume (model 1). The
total population consisted of 4472 individuals and the sliding window had a size of 2000 individuals (around 1750 after removing
related individuals, see Supplementary Table S1). We passed through the total population in 10 steps, i.e. moving by an average of 274
individuals in each step.
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It is therefore generally thought that the relative con-
tribution of genetics to the phenotypic variance might
decrease over time, but this is not well established in
humans. In a multi-generational cohort, four complex
traits were studied but there was little evidence for dif-
ferences over time in their heritability.32 For cognitive
ability, a gradual increase in the heritability has been
reported from infancy to adulthood,33–36 and it remains
high even in persons over 80 years old.37 The observed
increase in the heritability of cerebral blood ﬂow over
age could have several explanations. It is possible that
the genetic contribution remains stable but that envir-
onmental factors become less important with increasing
age. For example, the amount and variation in physical
Figure 2. Genome-wide association studies of cerebral blood flow. Manhattan plots for the genome-wide association studies of the
flow rate (top), vessel area (middle), and flow velocity (bottom) for three major cerebral arteries: variants with p-values <106 are
indicated in red for the basilar artery, green for the left carotid, and blue for the right carotid.
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exercise might decrease in the elderly, thereby causing
an apparent increase in the heritability. Also, some gen-
etic factors might exert their eﬀect on cerebral blood
ﬂow (more strongly) later in life, with a notable exam-
ple of such a gene being APOE. Additionally, pathol-
ogy-driven changes in the cerebral vasculature and
parenchyma, e.g. due to Alzheimer’s disease or stroke,
might make the cerebral blood ﬂow more dependent on
compensatory mechanisms. Their eﬀects might express
only late in life and in turn the heritability of the
response reaction cannot emerge early in life.
Heritability, which measures the eﬀect of all genetic
variants, does not necessarily imply greater success in
gene discovery, where each genetic variant is studied
separately. This is illustrated by the fact that our
genome-wide signiﬁcant ﬁndings were for the area
and velocity of the right carotid artery, parameters
which were not signiﬁcantly heritable. The top variants
for the two signiﬁcant loci were located in the introns of
FHL5 (6q16.1) and COL22A1 (8q24.23). FHL5, four-
and-a-half LIM domains 5, encodes a transcription
factor and was previously identiﬁed for migraine,26
and subsequently associated with cervical artery dissec-
tion.38 The gene is important for the proliferation of
vascular smooth muscle cells,39 pointing to a vascular
mechanism through which it could increase susceptibil-
ity to these diseases. Furthermore, a meta-analysis of
375,000 individuals recently revealed that migraine loci
are enriched for genes expressed in vascular and
smooth muscle tissues, largely in line with its proposed
vascular etiology.40 COL22A1, collagen type XXII
alpha 1, is part of the collagen protein family and vari-
ants in this gene have been associated with serum cre-
atinine41 and bronchodilator response in asthma,42
although these speciﬁc variants did not associate
with cerebral blood ﬂow in our study. While little is
known about the function of COL22A1, currently
unpublished results suggest it is important for main-
taining vascular integrity and mutations cause intracra-
nial aneurysms.43
The strengths of our study include its population-
based setting and comprehensive investigation of cere-
bral blood ﬂow parameters beyond the conventionally
studied ﬂow rate. Nevertheless, there are several limita-
tions. First, the sample is relatively small. This is
reﬂected in the standard errors of the heritability esti-
mates, especially for the sliding window analysis, and
this should caution against overinterpretation of the
results. For the association analyses, we countered the
small sample size by performing a replication study in
an independent cohort. While we are unware of other
population-based studies that have measured cerebral
blood ﬂow and genetics, larger collaborative studies
should be undertaken once these data become avail-
able. Second, our approach for estimating the heritabil-
ity in a sample of unrelated individuals by using
genotyped variants represents the narrow sense herit-
ability.20 This means that non-additive eﬀects and the
eﬀects of untagged causal variants will be disregarded,
thereby resulting in a potential underestimate. On the
other hand, simple family-based models have recently
been shown to inﬂate heritability estimates by almost
Table 3. Association of genome-wide significant loci with cerebral blood flow parameters in the Rotterdam Study.
rs12546630 rs2971609
Parameter N b (SE) P b (SE) P
Total cerebral blood flow 4453 .098 (.022) 7.41 106 .005 (.022) 0.8141
Flow rate
Basilar artery 4462 .002 (.025) 0.9429 .005 (.024) 0.849
Left carotid 4453 .080 (.024) 7.74 104 .004 (.024) 0.8661
Right carotid 4453 .116 (.024) 8.71 107 .013 (.024) 0.5807
Vessel area
Basilar artery 4440 .056 (.025) 0.02272 .034 (.025) 0.1683
Left carotid 4450 .100 (.024) 3.9 105 .096 (.024) 7.32 105
Right carotid 4454 .137 (.024) 2.02 108 .112 (.024) 3.67 106
Flow velocity
Basilar artery 4420 .057 (.024) 0.01628 .034 (.024) 0.1554
Left carotid 4415 .033 (.022) 0.136 .097 (.022) 7.88 106
Right carotid 4418 .033 (.022) 0.1302 .123 (.022) 1.36 108
Note: Effect estimates of the two genome-wide significant loci with cerebral blood flow parameters, adjusting for age, age2, sex, and intracranial volume
(model 1).
h2: heritability; N: sample size; SE: standard error.
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50% on average compared to estimates obtained from
structural equation modelling.44 Given the methodo-
logical considerations for determining which part of
the phenotypic variance is due to genetics, our ﬁndings
can provide a lower bound of the true heritability of
cerebral blood ﬂow. Third, when additionally adjusting
our analyses for total brain volume, we only used the
volume of the supratentorial grey and white matter.
This means that the cerebellum and brainstem, areas
that receive blood from the basilar artery, were unac-
counted for. We do not believe that this signiﬁcantly
inﬂuenced our ﬁndings since there were only marginal
diﬀerences (which generally were improvements) when
incorporating brain volume into the models. Fourth,
we used phase-contrast imaging to measure cerebral
blood ﬂow, but more sophisticated methods are avail-
able, which also generate regional ﬂow measures.
Functional MRI, arterial spin labeling, and positron
emission tomography are techniques that provide
more detailed information on regional blood ﬂow and
perfusion. Furthermore, longitudinal measurements,
both across the cardiac cycle (e.g. the peak systolic vel-
ocity) and across the lifespan, could be valuable in
understanding the role of genetics in diﬀerences over
time in cerebral blood ﬂow. Finally, our study was
included in persons of European descent, making the
results not readily generalizable to other ethnicities.
In conclusion, our study establishes cerebral blood
ﬂow as a trait with a complex genetic basis. Larger
studies can elucidate the genes underlying this intricate
process in the brain and perhaps further our under-
standing of related neurological diseases.
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